PRE 14A

Proxy Statement (Preliminary)

Cocrystal Pharma, Inc. Filed 2014-12-24 Acc 0001415889-14-003990

Documents 1

PRE 14A Proxy Statement (Preliminary) , cocrystalpre14adec2014.htm

Around this filing

2015-05-20 PRE 14A Proxy Statement (Preliminary)
2014-12-24 PRE 14A Proxy Statement (Preliminary)
2014-12-17 4 Director bought 25,000 shares at an average $0.43 ($10,769)

Link to a passage

External

SEC EDGAR (opens in new tab)